ClinicalTrials HQ

Alkermes, Inc.

Alkermes, Inc.

Explore linked clinical trials.

11 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic HypersomniaDisorders of Excessive Somnolence, Dyssomnias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, idiopathic hypersomnia, narcolepsy, narcolepsy without cataplexy, narcolepsy-cataplexy syndrome, nervous system disorder, psychiatric disorder, sleep-wake disorderRecruitingPhase 2 / Phase 32026-10-09NCT06767683
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)attention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorderRecruitingPhase 22026-10-07NCT07755410
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)Disorders of Excessive Somnolence, Dyssomnias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, Sleepiness, narcolepsy-cataplexy syndrome, nervous system disorder, psychiatric disorder, sleep-wake disorderRecruitingPhase 32026-10-07NCT07540897
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2Disorders of Excessive Somnolence, Dyssomnias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, narcolepsy without cataplexy, nervous system disorder, psychiatric disorder, sleep-wake disorderRecruitingPhase 32026-10-07NCT07502443
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, Fatigue, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, narcolepsy, narcolepsy-cataplexy syndrome, nervous system disorder, psychiatric disorder, sleep-wake disorderRecruitingPhase 32026-10-07NCT07455383
Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy ControlsSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingNot applicable2026-10-01NCT07680114
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic HypersomniaDisorders of Excessive Somnolence, Dyssomnias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, idiopathic hypersomnia, nervous system disorder, psychiatric disorder, sleep-wake disorderActive, not recruitingPhase 22026-09-25NCT06843590
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderSchizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, psychiatric disorder, schizophreniaRecruitingPhase 32026-08-14NCT05303064
Long-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsSchizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, psychiatric disorder, schizophreniaEnrolling by invitationPhase 32026-08-14NCT04987229
Naltrexone in AUD Reward DrinkersAlcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorderRecruitingPhase 42026-01-20NCT05028062
National Pregnancy Registry for Psychiatric Medicationsattention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorderRecruitingNot stated2025-10-24NCT01246765